Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Cancer | 5,829.0 | 6,119.0 | 6,031.0 | 5,849.0 | 5,612.0 | 5,639.0 | 4,933.0 | 5,596.0 |
| Medical and Other Health | 3,400.0 | 3,596.0 | 3,582.0 | 3,516.0 | 3,379.0 | 3,429.0 | 3,092.0 | 3,770.0 |
| Life insurance | 2,624.0 | 2,955.0 | 3,159.0 | 3,397.0 | 3,761.0 | 4,469.0 | 4,021.0 | 4,495.0 |
| Other | 3,072.0 | 2,701.0 | 2,541.0 | 2,444.0 | 2,276.0 | 2,408.0 | 2,395.0 | 2,694.0 |
| Aflac Japan revenues | 14,925.0 | 15,371.0 | 15,313.0 | 15,206.0 | 15,028.0 | 15,945.0 | 14,441.0 | 16,555.0 |
| Revenue growth [+] | -2.9% | 0.4% | 0.7% | 1.2% | -5.8% | 10.4% | -12.8% | -6.4% |
| Cancer | -4.7% | 1.5% | 3.1% | 4.2% | -0.5% | 14.3% | -11.8% | -8.6% |
| Medical and Other Health | -5.5% | 0.4% | 1.9% | 4.1% | -1.5% | 10.9% | -18.0% | -12.0% |
| Life insurance | -11.2% | -6.5% | -7.0% | -9.7% | -15.8% | 11.1% | -10.5% | -1.8% |
| Marketing | | | | | 100.0 | 100.0 | 82.0 | 103.0 |
| EBIT | 3,754.0 | 3,263.0 | 3,261.0 | 3,208.0 | 3,054.0 | 3,148.0 | 3,103.0 | 3,458.0 |
| EBIT margin | 25.2% | 21.2% | 21.3% | 21.1% | 20.3% | 19.7% | 21.5% | 20.9% |
| |
| Total assets | 128,536.0 | 137,271.0 | 127,523.0 | 118,342.0 | 114,402.0 | 107,858.0 | 97,646.0 | 98,525.0 |
| ROA | 2.4% | 2.7% | 1.9% | 2.0% | 3.1% | 1.9% | 2.1% | 2.3% |
| |
| Revenue Mix | 67.5% | 69.4% | 68.6% | 69.9% | 69.4% | 70.7% | 69.2% | 72.8% |
| EBIT Mix | 67.5% | 74.1% | 69.8% | 76.3% | 71.7% | 72.6% | 74.8% | 71.9% |
|